Initiatives addressing 8 material issues
First written in FY2021. 1 of 3 entries say "Reframed", first in FY2025. Latest entry: FY2026.
The whole theme swung hardest in 2019: 1 of 9 companies on the "Worse" side.
57 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Company is using the 8 material issues identified in the 25-27 medium-term management plan as the basis for business operations and management decisions, while working to clarify the allocation of management resources and the priorities of its initiatives.」
The Company progressed from identifying the 8 material issues to using them as the basis for business operations, management decisions, allocation of management resources and prioritization. - FY2025ReframedAnnual report
「In formulating the 25-27 Medium-Term Management Plan, the company reviewed its material sustainability issues and selected 8 areas: conservation of the global environment, stable supply of pharmaceuticals and services, contribution to regional healthcare, contribution to the development of the healthcare industry, promotion of employee success, compliance, risk management, and corporate governance.」
The Company reviewed the previous 8 material issues when formulating the 25-27 medium-term management plan and presented the details of the 8 items more specifically. - FY2021First statedAnnual report
「To achieve this, the company identified 8 material issues and is advancing related initiatives.」
The Company has identified 8 material issues as a framework for balancing the creation of profits, employment and customers with consideration of the social impact of corporate activities, with the aim of achieving sustainable growth and contributing to a sustainable society.